At the same time, health secretary Andrew Lansley announced today that the NHS will take forward plans to widen access for more cancer patients to molecular tests, which uses genomic technology as a tool  to provide targeted treatment for the individual patient. Testing of tumours and patients will be able to tell clinicians in advance whether a patient is likely to respond to particular drug therapies.